Updates

Supreme - Upgrades expectations by £4m (3rd upgrade)

December 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

A barnstorming set of interims with yet another significant upgrade. Having already seen EBITDA upgraded by c.£4m (see October issue), Supreme now expects to beat even that upgraded expectation by £4-5m with an expected outcome of between £32-35m. As it was, sales increased by 63% to c.£105m, with the Elf and Lost Mary distribution deal driving two thirds of the outperformance (incremental sales of £26.4m) and the other third (£13.6m) from its historical activities. Pretax profit increased 103% to £11.8m and eps by 80% to 8.1p. The interim dividend increased by 88% to 1.5p. As well as being hugely profitable and beating expectations, Sandy Chadha expects Elf to now make £7m profit versus £2m at the time of the deal. Not on ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Jet2

Dr. Martens

Supreme (February 2024)

Supreme (November 2023)

Supreme - Upgrades guidance by 17% (October 2023)

Supreme - Accelerated trading in the first three months (August 2023)

Supreme - Second “profits ahead of” statement in four months (May 2023)

Supreme - Sells Red Astaire vape brand for €4.5m cash (April 2023)

Supreme - Disposable vapes grows strongly (March 2023)

Supreme - Upgrade cycle resuming (December 2022)

Supreme (September 2022)

Supreme (August 2022)

Supreme - Eps enhancing acquisition of Liberty Flights (July 2022)

Supreme (May 2022)

Supreme - Shares break into new highs (January 2022)

Supreme (November 2021)

Supreme - Launches digital vitamin brand (August 2021)

Supreme - Expands sports nutrition capacity (July 2021)

Supreme (June 2021)

Supreme - Multi-stage rocket in consumer staples (March 2021)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X